Similarly, Quan et al. observed a decreased frequency of CD19+CD24highCD38high subsets and B10 in patients with NMO compared with those in patients with MS and controls, and the frequency was even lower in patients with AQP4-IgG-positive NMO (148). This evidence concerns the gene AQP4 and neuromyelitis optica.